Today: 9 June 2026
Netflix stock ticks up as Delaware judge blocks Paramount fast-track in Warner deal fight
15 January 2026
2 mins read

Netflix stock ticks up as Delaware judge blocks Paramount fast-track in Warner deal fight

New York, Jan 15, 2026, 12:16 EST — Regular session

  • Netflix shares edged up as a Delaware judge refused to fast-track Paramount Skydance’s lawsuit connected to Warner Bros Discovery’s deal process
  • The idea of an all-cash Netflix bid for Warner’s studios and streaming assets has resurfaced.
  • Investors are eyeing Netflix’s Jan. 20 earnings report for insights and any updates on deals

Shares of Netflix (NFLX.O) ticked up 0.6% to $89.08 midday Thursday, as investors digested a Delaware court decision related to its planned buyout of Warner Bros Discovery’s studios and streaming units.

The ruling keeps the takeover battle alive, leaving timing and price uncertain. Traders are watching the stock closely, viewing it as a gauge of whether Netflix can pull off a game-changing deal without stumbling over politics, financing, or regulatory hurdles.

Next Tuesday brings Netflix’s quarterly results, adding pressure to an already busy week. The Warner process looms large, casting uncertainty over what might have been a straightforward earnings report.

Reuters reported this week that Netflix plans to shift its bid to an all-cash offer for Warner’s studios and streaming units, moving away from an earlier $82.7 billion cash-and-stock deal. Paramount Skydance (PSKY.O) is also in the race, pushing a $30-per-share all-cash bid for the entire company. Lawmakers have raised alarms about increased media consolidation, warning it could limit consumer choice and drive up prices. Netflix has agreed to pay a $5.8 billion termination fee if regulators block the deal, while Warner would owe $2.8 billion should it walk away.

On Thursday, Delaware Chancery Court Vice Chancellor Morgan Zurn denied Paramount Skydance’s bid to fast-track its lawsuit demanding more details about Warner’s decision to support Netflix’s offer. Paramount said it would continue pushing for disclosures, while Warner dismissed the lawsuit as a distraction. Its lawyer told the court, “This movie is still being shot.” Paramount’s tender offer—aimed at buying shares directly from shareholders—is set to expire on Jan. 21. No vote on the Netflix deal has been scheduled yet, according to the report. Reuters

Shares of Warner Bros Discovery slipped 0.2%, while Paramount Skydance dipped 0.7% in midday trading.

Analysts are revising forecasts ahead of earnings. TD Cowen’s John Blackledge downgraded his price target to $115 from $142 but maintained a Buy rating. He cited the firm’s ad-buyer research, which signals “incremental advertiser adoption,” and noted consumer survey data that kept Netflix leading in living-room viewing this quarter. TipRanks

The downside is clear. An all-cash deal might spark concerns over balance-sheet pressure. Plus, a lengthy regulatory review could drag out the Warner bid, weighing on the stock despite Netflix’s core business staying strong.

Netflix will release its fourth-quarter results and business outlook on Jan. 20 around 1:01 p.m. Pacific time, with a management video interview set for 1:45 p.m. Pacific time.

Next week’s numbers will draw investor attention to any update on the Warner bid, the outlook on advertising and margins, and how much room Netflix claims it has left for strategic spending.

Stock Market Today

  • How Teens Can Use Summer Jobs to Build $500,000 in Savings
    June 9, 2026, 10:39 AM EDT. Teenagers who take on summer jobs gain more than just work experience-they acquire critical financial skills and early capital to invest. Starting to invest money earned from summer jobs during teenage years can significantly boost savings over time. Leveraging compound interest, teens can potentially accumulate up to $500,000 or more by adulthood. Experts emphasize the importance of early saving and investing to maximize growth. Those who skip summer jobs miss out on this critical opportunity to build a robust financial foundation for their future.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
POET Technologies stock climbs before the bell as call-option volume spikes
Previous Story

POET Technologies stock climbs before the bell as call-option volume spikes

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead
Next Story

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead

Go toTop